Xiaoning Mo

1.2k total citations
36 papers, 763 citations indexed

About

Xiaoning Mo is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Xiaoning Mo has authored 36 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Xiaoning Mo's work include Chemokine receptors and signaling (13 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (8 papers). Xiaoning Mo is often cited by papers focused on Chemokine receptors and signaling (13 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (8 papers). Xiaoning Mo collaborates with scholars based in China, United States and Macao. Xiaoning Mo's co-authors include Wenling Han, Dalong Ma, Pingzhang Wang, Ting Li, Baocai Liu, Quansheng Song, Yingmei Zhang, Wanqiong Yuan, Wenyan Wang and Xiaolin Wang and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and The FASEB Journal.

In The Last Decade

Xiaoning Mo

35 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoning Mo China 18 335 307 268 169 113 36 763
Song Yi Ko United States 15 516 1.5× 283 0.9× 358 1.3× 255 1.5× 65 0.6× 20 948
Chris K. Neeley United States 12 281 0.8× 467 1.5× 341 1.3× 132 0.8× 188 1.7× 13 849
Hanne Vos Belgium 4 261 0.8× 338 1.1× 359 1.3× 107 0.6× 70 0.6× 12 687
Zhangyan Guo China 13 441 1.3× 312 1.0× 269 1.0× 317 1.9× 119 1.1× 18 917
Naiara Perurena United States 10 337 1.0× 359 1.2× 631 2.4× 143 0.8× 153 1.4× 15 1.1k
Marie-Pierre Podgorniak France 14 364 1.1× 337 1.1× 105 0.4× 130 0.8× 102 0.9× 20 648
Ileana Bortolomai Italy 17 283 0.8× 246 0.8× 122 0.5× 84 0.5× 57 0.5× 20 586
Amy J. Petty United States 11 271 0.8× 344 1.1× 497 1.9× 88 0.5× 80 0.7× 20 854
Robert Seed United Kingdom 13 236 0.7× 192 0.6× 136 0.5× 113 0.7× 79 0.7× 18 547

Countries citing papers authored by Xiaoning Mo

Since Specialization
Citations

This map shows the geographic impact of Xiaoning Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoning Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoning Mo more than expected).

Fields of papers citing papers by Xiaoning Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoning Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoning Mo. The network helps show where Xiaoning Mo may publish in the future.

Co-authorship network of co-authors of Xiaoning Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoning Mo. A scholar is included among the top collaborators of Xiaoning Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoning Mo. Xiaoning Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xixi, Kai Zhang, Xiulan Yang, et al.. (2025). The cytokine CSBF inhibits the IL-17A and TNF-α inflammatory pathways via SUSD2-ACT1 in keratinocytes and alleviates IMQ-induced psoriasis. Cellular and Molecular Immunology. 22(9). 1109–1122.
2.
Mo, Xiaoning, et al.. (2022). Removal of polybrominated diphenyl ethers in high impact polystyrene (HIPS) from waste TV sets. Environmental Science and Pollution Research. 29(39). 59317–59327. 3 indexed citations
3.
Yuan, Wanqiong, Feng Wei, Hanqiang Ouyang, et al.. (2021). CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway. Cancer Cell International. 21(1). 510–510. 17 indexed citations
4.
Xue, Hui, Ting Li, Pingzhang Wang, et al.. (2019). CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer. Acta Biochimica et Biophysica Sinica. 51(9). 915–924. 22 indexed citations
5.
Shi, Zhan, Qingyang Zhang, Ying Yang, et al.. (2019). More than one antibody of individual B cells revealed by single-cell immune profiling. Cell Discovery. 5(1). 64–64. 43 indexed citations
6.
Xia, Peng, Yida Wang, Tianzhuo Zhang, et al.. (2018). CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Brain Behavior and Immunity. 71. 158–168. 9 indexed citations
7.
Liu, Weili, Ting Li, Pingzhang Wang, et al.. (2017). LRRC25 plays a key role in all-trans retinoic acid-induced granulocytic differentiation as a novel potential leukocyte differentiation antigen. Protein & Cell. 9(9). 785–798. 6 indexed citations
8.
Pei, Xiaolei, Danfeng Zheng, Shaoping She, et al.. (2017). The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis. Scientific Reports. 7(1). 5107–5107. 14 indexed citations
9.
Liu, Baocai, Henan Li, Weiwei Fu, et al.. (2016). CMTM3 presents a secreted form released via exosomes. Acta Biochimica et Biophysica Sinica. 48(6). 584–586. 5 indexed citations
10.
Fu, Weiwei, Yingying Cheng, Yanfei Zhang, et al.. (2015). The Secreted Form of Transmembrane Protein 98 Promotes the Differentiation of T Helper 1 Cells. Journal of Interferon & Cytokine Research. 35(9). 720–733. 18 indexed citations
11.
Li, Ting, Yingying Cheng, Pingzhang Wang, et al.. (2015). CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 34(1). 122–122. 50 indexed citations
12.
Zhang, Shiying, Xiaolei Pei, Hao Hu, et al.. (2015). Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer. Tumor Biology. 37(5). 6217–6225. 14 indexed citations
13.
Zhang, Guoying, Yang Luo, Ge Li, et al.. (2014). DHRSX, A Novel Non-Classical Secretory Protein Associated With Starvation Induced Autophagy. International Journal of Medical Sciences. 11(9). 962–970. 9 indexed citations
14.
Wang, Jing, Guoying Zhang, Yingmei Zhang, et al.. (2014). CMTM1_v17 is a novel potential therapeutic target in breast cancer. Oncology Reports. 32(5). 1829–1836. 18 indexed citations
15.
Guo, Xiaohuan, Yanfei Zhang, Pingzhang Wang, et al.. (2012). VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells. Cellular Immunology. 278(1-2). 136–142. 29 indexed citations
16.
Li, Ting, Yu Wang, Xiaoning Mo, et al.. (2010). Identification and Characterization of CMTM4, a Novel Gene with Inhibitory Effects on HeLa Cell Growth through Inducing G2/M Phase Accumulation. Molecules and Cells. 29(4). 355–362. 41 indexed citations
17.
Li, Ting, Xiaoning Mo, Otto Majdic, et al.. (2010). Expressional and functional studies of CKLF1 during dendritic cell maturation. Cellular Immunology. 263(2). 188–195. 20 indexed citations
18.
Li, Henan, et al.. (2010). CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway. BMB Reports. 43(3). 182–187. 20 indexed citations
19.
Wang, Yu, Ting Li, Xiaoyan Qiu, et al.. (2008). CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochemical and Biophysical Research Communications. 371(1). 54–58. 27 indexed citations
20.
Wang, Yu, Xiaoyan Qiu, Xiaoning Mo, et al.. (2006). Characterization and Expression Profile of CMTM3/CKLFSF3. BMB Reports. 39(5). 537–545. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Song Yi Ko Breakdown of academic impact, for papers by Chris K. Neeley Breakdown of academic impact, for papers by Hanne Vos Breakdown of academic impact, for papers by Zhangyan Guo Breakdown of academic impact, for papers by Naiara Perurena Breakdown of academic impact, for papers by Marie-Pierre Podgorniak Breakdown of academic impact, for papers by Ileana Bortolomai Breakdown of academic impact, for papers by Amy J. Petty Breakdown of academic impact, for papers by Robert Seed
Rankless by CCL
2026